Riitta Lassila/LinkedIn
Nov 15, 2026, 15:33
Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
Riitta Lassila, Professor of Coagulation Medicine at University of Helsinki, shared a post on LinkedIn:
“It was an utmost honor and pleasure to follow the thesis discussion by Prof. Marc Carrier with excellent questions and education during Lasse Myllylahti’s defense on Nov 13 in Helsinki University Hospital, Finland.
Lasse managed well.
Marc gave great ideas for further research in VTE, epidemiology, role of perioperative issues in CTEPH, ovarian cancer and immunothrombosis.
Looking forward to joining ISTH 2027 in June in Vancouver where Marc will be the President.”
Other posts feauturing Riitta Lassila on Hemostatis Today.
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice
-
Nov 15, 2026, 15:03Francesco Antonio Veneziano: Rethinking Coronary Artery Disease Through Precision Cardiology
-
Nov 15, 2026, 14:37Denise Rezende: 100 Years of von Willebrand Disease and Advances in Diagnosis
-
Nov 15, 2026, 14:22Ahmed Alotaibi: Does Donor Sex Influence Platelet Storage Quality
-
Nov 15, 2026, 14:09Stephen Alerhand: Acute Pulmonary Embolism vs Chronic Pulmonary Hypertension
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility